Abstract

Transcatheter aortic valve implantation (TAVI) is an emerging treatment option for inoperable or high risk patients. Low implantation (over 8mm) has been frequently implicated with moderate or severe paravalvular aortic regurgitation (PVR). However, it has not been evaluated the effect of high

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call